HKU Scholars Hub: Browsing DSpace

Browsing by Journal/Conference lung cancer

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 20 of 31 next >

Title	Author(s)	Issue Date
Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas Journal:Lung Cancer	LUO, SY Sit, AKY Sihoe, DLA Suen, WS Au, TWK Tang, X Ma, ESK Chan, WK Wistuba, II Minna, JD Tsao, GSW Lam, CLD	2014
Characterizing immune-mediated adverse events with durvalumab in patients with unresectable stage III NSCLC: A post-hoc analysis of the PACIFIC trial Journal:Lung Cancer	Naidoo, Jarushka Vansteenkiste, Johan F.Faivre-Finn, Corinne Özgüroğlu, Mustafa Murakami, Shuji Hui, Rina Quantin, Xavier Broadhurst, Helen Newton, Michael Thiyagarajah, Piruntha Antonia, Scott J.	2022
Chemotherapy in advanced lymphoepithelioma-like carcinoma (LELC) of lung Proceeding/Conference:Lung Cancer	Ho, JCM Lam, WK Ooi, CGC Tsang, KWT Wong, MP	2000
Clinical treatment patterns, molecular characteristics and survival outcomes of ROS1-rearranged non-small cell lung cancer: A large multicenter retrospective study Journal:Lung Cancer	Huang, Zhe Zhang, Yuda Xu, Qinqin Song, Lianxi Li, Yizhi Guo, Wenhuan Lin, Shaoding Jiang, Wenjuan Wang, Zhan Deng, Li Qin, Haoyue Zhang, Xing Tong, Fan Zhang, Ruiguang Liu, Zhaoyi Zhang, Lin Yu, Juan Dong, Xiaorong Gong, Qian Deng, Jun Chen, Xue Wang, Jing Zhang, Gao Yang, Nong Zeng, Liang Zhang, Yongchang	20-May-2024
Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies Journal:Lung Cancer	Wu, YL Lee, VHF Liam, CK Lu, S Park, K Srimuninnimit, V Wang, J Zhou, CC Appius, A Button, P Hooper, G Palma, JF Schulze, K Scudder,, S Shames, DS Yin, AY Zhang, GL Mok, T	2018
Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure Journal:Lung Cancer	Lam, TC Tsang, KC Choi, HC Lee, VH Lam, KO Chiang, CL So, TH Chan, WW Nyaw, SF Lim, F Lau, JO Chik, J Kong, FM Lee, AW	2021
Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma Journal:Lung Cancer	Lam, SK LEUNG, LL Li, YV Zheng, C Ho, JCM	2016
Combination of arsenic trioxide and chemotherapy in small cell lung cancer Journal:Lung Cancer	ZHENG, C Lam, SK LI, Y Fong, BM Mak, JCW Ho, JCM	2013
EGFR testing in paraffin-embedded cell block cytology material is reliable with increased detection for effusion fluid Journal:Lung Cancer	Man Ng, Joanna Ka Chow, Chit Kin Chan, Ronald Cheong Pang Chan, Ka Xi Li, Joshua Jing Ching Li, Molly Siu To, Ka Fai	2022
Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer Journal:Lung cancer	Li, Y Lam, SK Mak, JCW Zheng, C Ho, JCM	2013
Genetic changes in non-smoking Chinese women with lung cancer Proceeding/Conference:Lung Cancer	Lam, WK Wong, MP Lung, ML Tsang, KWT Ip, MSM Fu, KH Chiu, SW Yew, WW	2000
Genetic predisposition to lung adenocarcinoma among never-smoking Chinese with different epidermal growth factor receptor mutation status Journal:Lung Cancer	Han, L Lee, CK Pang, H Chan, HT Lo, IL Lam, SK Cheong, TH Ho, JCM	2017
Haematological toxicity of pemetrexed in patients with metastatic non-squamous non-small cell carcinoma of lung with third-space fluid Journal:Lung Cancer	Kwok, WC Cheong, TF Chiang, KY Ho, JCM Lam, DCL Ip, MSM Tam, TCC	2021
IL-9 stimulates an anti-tumor immune response and facilitates immune checkpoint blockade in the CMT167 mouse model Journal:Lung Cancer	Feng, Yuqian Yan, Sheng Lam, Sze Kwan Ko, Frankie Chi Fat Chen, Caoyang Khan, Mahjabin Ho, James Chung Man	11-Oct-2022
Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC) Journal:Lung Cancer	Faivre-Finn, Corinne Spigel, David R.Senan, Suresh Langer, Corey Perez, Bradford A.Özgüroğlu, Mustafa Daniel, Davey Villegas, Augusto Vicente, David Hui, Rina Murakami, Shuji Paz-Ares, Luis Broadhurst, Helen Wadsworth, Catherine Dennis, Phillip A.Antonia, Scott J.	2021
Implementation of hypoxia measurement into lung cancer therapy Journal:Lung Cancer	Meng, Xue Kong, Feng Ming Spring Yu, Jinming	2012
Management of co-existent tuberculosis and lung cancer Journal:Lung Cancer	Ho, JCM Leung, CC	2018
Natural growth and disease progression of non-small cell lung cancer evaluated with 18F-fluorodeoxyglucose PET/CT Journal:Lung Cancer	Wang, Jingbo Mahasittiwat, Pawinee Wong, Ka Kit Quint, Leslie E.Kong, Feng Ming Spring	2012
Non-small cell lung cancer: when to offer sublobar resection Journal:Lung Cancer	Sihoe, ADL Van Schil, P	2014
Plasma transforming growth factor-β1 reflects disease status in patients with lung cancer after radiotherapy: A possible tumor marker Journal:Lung Cancer	Kong, Feng Ming Washington, Mary Kay Jirtle, Randy L.Anscher, Mitchell S.	1996

Showing results 1 to 20 of 31 next >